共 247 条
[1]
Rowen D(2017)International regulations and recommendations for utility data for health technology assessment PharmacoEconomics 35 11-19
[2]
Zouraq IA(2020)Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines The European Journal of Health Economics 18 395-415
[3]
Chevrou-Severac H(2018)eq5dmap: A command for mapping between EQ-5D-3L and EQ-5D-5L The Stata Journal 146 317-325
[4]
van Hout B(2007)Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection Annals of Internal Medicine 166 1092-1097
[5]
Kennedy-Martin M(2006)A brief measure for assessing generalized anxiety disorder: The GAD-7 Archives of Internal Medicine 16 606-613
[6]
Slaap B(2001)The PHQ-9: Validity of a brief depression severity measure Journal of General Internal Medicine 51 597-606
[7]
Herdman M(2013)Enhancing recovery rates: Lessons from year one of IAPT Behaviour Research and Therapy 11 415-432
[8]
Reenen M(2016)Cost-effectiveness thresholds in health care: A bookshelf guide to their meaning and use Health Economics, Policy and Law 26 733-744
[9]
Kennedy-Martin T(2008)The NICE cost-effectiveness threshold PharmacoEconomics 13 70-75
[10]
Greiner W(2008)Measuring and valuing mental health for use in economic evaluation Journal of Health Services Research & Policy 18 vii-243